Skip to content

Pfizer Gets Nod From EU Regulator for Covid Drug Paxlovid

  • Pill is the first oral Covid treatment recommended in EU
  • Regulator is still reviewing Merck’s Covid drug molnupiravir
Video player cover image
Pfizer Covid Pill Stops Unvaccinated Hospitalizations
Updated on

Pfizer Inc.’s Covid-19 pill received backing from the European Union’s drugs regulator, offering a tool to manage coronavirus infections at home and ease the burden on hospitals.

The European Medicines Agency’s expert committee recommended granting conditional marketing authorization for the antiviral, called Paxlovid, for adults with Covid who don’t require supplemental oxygen and are at risk of developing severe disease, the regulator said Thursday.